Abstract
The aim of this paper is to supplement the GEC/ESTRO/EAU recommendations for permanent
seed implantations in prostate cancer to develop consistency in target and volume
definition for permanent seed prostate brachytherapy.
Recommendations on target and organ at risk (OAR) definitions and dosimetry parameters
to be reported on post implant planning are given.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Radiotherapy and OncologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Pre-and post-implant dosimetry: an inter-comparison between UK prostate brachytherapy centres.Radiother Oncol. 2002; 66: 181-183
- Impact of prostate volume evaluation by different observers on CT-based post-implant dosimetry.Radiother Oncol. 2002; 62: 267-273
- Prostate seed implant quality assessment using MR and CT image fusion.Int J Radiat Oncol Biol Phys. 1999; 43: 67-72
- ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer.Radiother Oncol. 2000; 57: 315-321
- MR-guided interventions for prostate cancer.Magn Reson Imaging Clin N Am. 2005; : 13
- Variability and accuracy of measurements of prostate brachytherapy seed position in vitro using three-dimensional ultrasound: an intra- and interobserver study.Med Phys. 2000; 27: 2788-2795
- Imaging for prostate cancer.Clin Oncolo (R Coll Radiol). 2005; 17: 553-559
- Prostate cancer brachytherapy: Is real-time ultrasound-based dosimetry predictive of subsequent CT-based dose distribution calculation? A study of 450 patients by the Institut Curie/Hospital Cochin (Paris) Group.Int J Radiat Oncol Biol Phys. 2004; 59: 691-695
- Iodin 125 seed migration after prostate brachytherapy: a study of 170 patients.Cancer Radiother. 2004; 8: 211-216
- Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications.J Urol. 1997; 157: 559-562
- The changing face of prostate cancer.J Clin Oncol. 2005; 23: 8146-8151
- Optimizing target coverage by dosimetric feedback during prostate brachytherapy.Int J Radiat Oncol Biol Phys. 2000; 48: 1245-1249
- MRI-CT fusion to assess postbrachytherapy prostate volume and the effects of prolonged edema on dosimetry following transperineal interstitial permanent prostate brachytherapy.Brachytherapy. 2004; 3: 55-60
- Interobserver variation in postimplant computed tomography contouring affects quality assessment of prostate brachytherapy.Brachytherapy. 2002; 1: 66-73
- Critical organ dosimetry in permanent seed prostate brachytherapy: defining the organs at risk.Brachytherapy. 2005; 4: 186-194
- Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.JAMA. 1998; 280: 969-974
- Permanent prostate brachytherapy (PPB) as it concerns seed migration and extraprostatic seed placement.Cancer J. 2005; 11: 147-151
- Treatment of extraprostatic cancer in clinically organ-confined prostate cancer by permanent interstitial brachytherapy: is extraprostatic seed placement necessary?.Tech Urol. 2000; 6: 70-77
- The radial distance of extraprostatic extension of prostate carcinoma: implications for prostate brachytherapy.Cancer. 1999; 85: 2630-2637
- The contribution of magnetic resonance imaging to the three-dimensional treatment planning of localized prostate cancer.Int J Radiat Oncol Biol Phys. 1999; 45: 857-865
- Accuracy of seed reconstruction in prostate postplanning studies with a CT- and MRI-compatible phantom.Radiother Oncol. 2006; ([epub ahead of print])
- Effect of prostatic edema on CT-based post-implant dosimetry.Int J Radiat Oncol Biol Phys. 2002; 53: 483-489
- Source localization following permanent transperineal prostate interstitial brachytherapy using magnetic resonance imaging.Int J Radiat Oncol Biol Phys. 1997; 39: 1037-1041
- The evaluation of radical prostatectomy specimens performed for carcinoma of the prostate. Therapeutic and prognostic implications.Pathol Ann. 1991; 26: 159-210
- Radioactive seed migration to the chest after transperineal interstitial prostate brachytherapy: Extraprostatic seed placement correlates with migration.Int J Radiat Oncol Biol Phys. 2004; 59: 419-425
- Prostate brachytherapy seed migration and dosimetry: analysis of stranded sources and other potential predictive factors.Brachytherapy. 2004; 3: 10-19
CT-ultrasound fusion prostate brachytherapy: a dynamic dosimetry feedback and improvement method – A report of 54 consecutive cases. Fuller DB, Jin H, Kowiol JA, Feng AC. Brachytherapy 2005;4:207–16.
- Ultrasonography and fluoroscopic fusion for prostate brachytherapy dosimetry.Int J Radiat Oncol Biol Phys. 2002; 54: 1322-1330
- Recommendations from Gynaecological (GYN GEC-ESTRIO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GRV and CTV.Radiother Oncol. 2005; 74: 235-245
- Prostate brachytherapy seed identification on post-implant TRUS images.Med Phys. 2003; 30: 898-900
- The effect of interobserver differences in post-implant prostate CT image interpretation on dosimetric parameters.Med Phys. 2003; 30: 1096-1102
- Cell kinetic measurements in prostate cancer.Int J Radiat Oncol Biol Phys. 1997; 37: 1067-1070
- Impact of selection of post-implant technique on dosimetry parameters for permanent prostate implants.Brachytherapy. 2005; 4: 146-153
- Impact of target volume coverage with Radiation Therapy Oncology Group (RTOG) 98-05 guidelines for transrectal ultrasound guided permanent Iodine-125 prostate implants.Radiother Oncol. 2003; 66: 173-179
ICRU Report 58. Dose and volume specification for reporting interstitial brachytherapy, International Commission on Radiation Units and Measurements, ICRU, Bethesda, Maryland, USA; 1997.
- GEC/ESTRO-EAU recommendations on temporary brachytherapy using stepping sources for localised prostate cancer.Radiother Oncol. 2005; 74: 137-148
- Migration of implanted free radioactive seeds for adenocarcinoma of the prostate using a Mick applicator.Brachytherapy. 2004; 3: 71-77
- Recommendations of the Braphyqs Prostate Sub-Group, the clinical part of the questionnaire.Radiother Oncol. 2005; 75 (abstract 49): S22
- Postimplant analysis of transperineal intestitial permanent prostate brachytherapy: evidence for a learning curve in the first year at a single institution.Int J Radiat Oncol Biol Phys. 2000; 46: 83-88
- Interobserver variability leads to significant differences in quantifiers of prostate implant adequacy.Int J Radiat Oncol Biol Phys. 2002; 54: 457-461
- Recommendations of the Braphyqs Prostate Sub-Group, the physics part of the questionnaire.Radiother Oncol. 2005; 75 (abstract 50): S23
- Comparative study of permanent interstitial prostate brachytherapy post-implant evaluation among seven Italian institutes.Radiother Oncol. 2004; 71: 13-21
- Comparison of MRI pulse sequences in defining prostate volume after permanent implantation.Int J Radiat Oncol Biol Phys. 2002; 54: 703-711
- Modified uniform seed loading for prostate brachytherapy: rationale, design and evaluation.Tech Urol. 2000; 6: 78
- Seed fixicity in the prostate/periprostatic region following brachytherapy.Int J Radiat Oncol Biol Phys. 2000; 46: 215-220
- Permanent interstitial brachytherapy for the management of carcinoma of the prostate gland.J Urol. 2003; 169: 1643-1652
- Evaluation of permanent I-125 prostate implants using radiography and magnetic resonance imaging.Int J Radiat Oncol Biol Phys. 1997; 37: 927-933
- The American Brachytherapy Society recommendations for permanent prostate brachytherapy post-implant dosimetric analysis.Int J Radiat Oncol Biol Phys. 2000; 46: 221-230
- American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer.Int J Radiat Oncol Biol Phys. 1999; 44: 789
- Impact of differences in ultrasound and computed tomography volumes on treatment planning of permanent prostate implants.Int J Radiat Oncol Biol Phys. 1997; 37: 1181-1185
- Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No 43.Med Phys. 1995; 22: 209-234
- Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathologic stage in 275 patients with clinically localized adenocarcinoma of the prostate.J Urol. 1987; 138: 92-98
- Radioactive implant migration in patients treated for localized prostate cancer with interstitial brachytherapy.J Urol. 2001; 165: 1590-1592
- Standardization of prostate brachytherapy treatment plans.Int J Radiat Oncol Biol Phys. 2001; 50: 257-263
- Prostate specific antigen in the staging of localised prostate cancer: influence of tumour differentiation, tumour volume and benign hyperplasia.J Urol. 1990; 143: 747-752
- Morphometric measurements of tumor volume and per cent of gland involvement as predictor of pathological stage in clinical stage B prostate cancer.J Urol. 1989; 141: 341-345
- Combination of prostate specific antigen,clinical stage and Gleason score to predict pathologic stage of localised prostate cancer.JAMA. 1997; 277: 1445-1451
- Sextant prostate biopsies. A histopathologic correlation with radical prostatectomy specimen.Cancer. 1995; 75: 530-538
- MR and CT image fusion for postimplant analysis in permanent prostate seed implants.Int J Radiat Oncol Biol Phys. 2004; 60: 1572-1579
- Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image based treatment planning in cervix cancer brachytherapy – 3D dose volume parameters and aspects of 3D image-based anatomy, radiations physics, radiobiology.Radiother Oncol. 2006; 78: 67-77
- Towards a dynamic real-time intraoperative permanent prostate brachytherapy methodology.Brachytherapy. 2003; 2: 172-180
- A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy.Int J Radiat Oncol Biol Phys. 2001; 50: 605-614
- Monotherapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation.Radiother Oncol. 2004; 71: 29-33
- Timing of computed tomography-based postimplant assessment following permanent transperineal prostate brachytherapy.Int J Radiat Oncol Biol Phys. 1998; 40: 1111-1115
- Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma.Cancer. 1998; 83: 989-1001
- Modern prostate brachytherapy. Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up.Cancer. 2000; 89: 135-141
- Update of AAPM TG 43: a revised AAPM protocol for brachytherapy dose calculations.Med Phys. 2004; 31: 633-674
- Source placement error for permanent implant of the prostate.Med Phys. 1997; 24: 251-257
RTOG 98-05. Phase II Trial of transrectal ultrasound guided permanent radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate.
- 103Pd brachytherapy versus radical prostatectomy in patients with clinically localized prostate cancer: a 12-year experience from a single group practice.Brachytherapy. 2005; 4: 33-34
- The design and testing of a solid phantom for the verification of a commercial 3D seed reconstruction algorithm.Radiother Oncol. 2005; 74: 169-175
- Seed loss in interstitial radiotherapy of prostatic carcinoma with 125I.Int J Radiat Oncol Biol Phys. 1988; 14: 389-392
- Morphometric and clinical studies on 68 consecutive radical prostatectomies.J Urol. 1988; 139: 1235-1241
- Importance of post-implant dosimetry in permanent prostate brachytherapy.Eur Urol. 2002; 41: 434-439
- Postimplant dosimetry for 125I prostate implants: definitions and factors affecting outcome.Int J Radiat Oncol Biol Phys. 2000; 48: 899-906
- Prostate brachytherapy, treatment strategies.J Urol. 1999; 162: 421-426
- Examination of dosimetry accuracy as a function of seed detection rate in permanent prostate brachytherapy.Med Phys. 2005; 32: 3049-3056
- Intraoperative dynamic dosimetry for prostate implants.Phys Med Biol. 2003; 48: 1153-1171
- Trends in prostate cancer epidemiology in the year 2000.Arch Ital Urol Androl. 2005; 77: 164-166
- A population model of prostate cancer incidence.Stat Med. 2006;
- Biologically effective dose for permanent prostate brachytherapy taking into account postimplant edema.Int J Radiat Oncol Biol Phys. 2002; 53: 422-433
- Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy.Int J Radiat Oncol Biol Phys. 1995; 32: 465-471
- Effect of prostatic edema on CT-based postimplant dosimetry.Int J Radiat Oncol Biol Phys. 1998; 41: 1069-1077
- Recommendations of the American Association of Physicists in Medicine on 103Pd interstitial source calibration and dosimetry: implications for dose specification and prescription.Med Phys. 2000; 27: 634-642
- Permanent prostate seed implant brachytherapy: report of the AAPM TG 64.Med Phys. 1999; 26: 2054-2076
- Optimum timing for image-based dose evaluation of 125I and 103Pd prostate seed implants.Int J Radiat Oncol Biol Phys. 1999; 45: 1063-1072
- Improved conformality and decreased toxicity with intraoperative computer-optimized transperineal ultrasound-guided prostate brachytherapy.Int J Radiat Oncol Biol Phys. 2003; 55: 956-963
Article info
Publication history
Published online: February 28, 2007
Accepted:
January 29,
2007
Received in revised form:
January 17,
2007
Received:
November 6,
2006
Identification
Copyright
© 2007 Published by Elsevier Inc.
